Modeling Stroke in Mice: Focal Cortical Lesions by Photothrombosis
May 6th, 2021
7K views
Described here is the photothrombotic stroke model, where a stroke is produced through the intact skull by inducing permanent microvascular occlusion using laser illumination after administration of a photosensitive dye.
Overview
This article demonstrates a standardized photothrombotic mouse model for inducing focal cortical stroke using intraperitoneal injection of Rose Bengal and targeted 561 nm laser illumination. The protocol enables precise, reproducible induction of cortical lesions without invasive surgery, facilitating studies of post-stroke mechanisms and therapeutic interventions. Detailed surgical steps and histological analysis methods are provided to support reproducibility and address the replication crisis in preclinical stroke research.
Key Study Components
Area of Science
- Neuroscience
- Stroke research
- Experimental models
Background
- Stroke is a major cause of death and disability worldwide.
- Current therapeutic options for stroke are limited, necessitating further research into pathophysiological mechanisms such as inflammation, angiogenesis, and neuronal plasticity.
- In vitro models cannot fully replicate brain complexity, making in vivo models essential for studying stroke and evaluating new drug targets.
- Standardized, reproducible animal models are needed to improve research reliability and address the replication crisis.
Purpose of Study
- To present a detailed, standardized protocol for photothrombotic stroke induction in mice.
- To enable targeted induction of cortical lesions with high reproducibility and low mortality.
- To facilitate the study of post-stroke mechanisms and evaluation of therapeutic strategies.
Methods Used
- Preparation of Rose Bengal solution (10 mg/mL in 0.9% saline).
- Intraperitoneal injection of Rose Bengal, with dose adjusted to mouse body weight.
- Targeted illumination of the intact skull with a 561 nm laser for 20 minutes at specified cortical coordinates.
- Post-surgical care including wound suturing and recovery monitoring.
- Histological analysis using crystal violet and TUNEL staining to assess infarct volume and tissue damage.
- Behavioral assessment using composite neuro score.
Main Results
- The model produced well-demarcated, reproducible cortical lesions with low variability (mean infarct volume: 29.3 mm³, ~23% of one hemisphere).
- Stroke induction resulted in moderate, long-term sensorimotor impairment, with significant neuro score changes at 24 hours and gradual improvement over time.
- Body weight and temperature decreased 24 hours post-surgery but recovered within three days.
- Lesions were only observed when both Rose Bengal and laser illumination were applied simultaneously; controls showed no tissue damage.
- The protocol is compatible with in vivo imaging techniques due to the intact skull.
Conclusions
- The photothrombotic stroke model allows precise, reproducible induction of cortical lesions in mice without invasive surgery.
- It is suitable for cellular and molecular studies of cortical plasticity and post-stroke mechanisms.
- Standardization of this protocol supports reproducibility and reliability in preclinical stroke research.
Frequently Asked Questions
What are the main advantages of the photothrombotic stroke model?
The model allows precise targeting of lesions to specific cortical regions, offers high reproducibility, and has low mortality compared to other stroke models.
How is the stroke induced in this protocol?
Stroke is induced by intraperitoneal injection of Rose Bengal followed by targeted illumination of the intact skull with a 561 nm laser at the desired cortical location.
Why is standardization important in stroke models?
Standardization ensures reproducibility and reliability of results, which is critical for addressing the replication crisis in preclinical research.
How is infarct volume assessed in this model?
Infarct volume is measured using crystal violet staining of serial coronal brain sections and confirmed with TUNEL staining for tissue damage assessment.
What behavioral outcomes are measured after stroke induction?
Sensorimotor impairment is assessed using a composite neuro score, which shows significant changes after stroke and gradual recovery over time.
Can this protocol be combined with in vivo imaging?
Yes, since the skull remains intact, the protocol is compatible with wide-field or multiphoton in vivo imaging techniques.
What controls are used to confirm lesion specificity?
Controls include Rose Bengal injection or laser illumination alone, neither of which produces lesions; only the combination results in a well-demarcated infarct.
Executive Industry Relevance
Standardized photothrombotic stroke models in mice address critical gaps in preclinical target validation for cerebrovascular disease by enabling reproducible, region-specific cortical lesions. This model supports predictive confidence in evaluating post-stroke mechanisms and therapeutic hypotheses, directly impacting early discovery and translational research pipelines. Its reproducibility and compatibility with advanced imaging facilitate robust cross-study comparisons and enterprise-level portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise interrogation of post-stroke pathways such as inflammation, angiogenesis, and neuronal plasticity.
- Supports functional target validation by generating consistent, well-demarcated cortical lesions.
- Facilitates mechanistic de-risking through controlled lesion induction and outcome measurement.
- Improves predictive confidence for advancing novel therapeutic targets.
Screening & Assay Development
- Provides a validated in vivo system for quantitative assessment of candidate interventions.
- Ensures assay reproducibility and standardization across studies and teams.
- Delivers robust, quantifiable outputs such as infarct volume and neurobehavioral scores.
- Enables scalable screening of neuroprotective or regenerative compounds.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints for translational biomarker development.
- Maintains continuity from discovery through preclinical validation by supporting longitudinal studies.
- Reduces translational risk by modeling clinically relevant stroke phenotypes.
- Supports risk-adjusted advancement of therapeutic candidates targeting post-stroke recovery.
Pipeline & Workflow Integration
This photothrombotic model integrates from early discovery through preclinical validation, supporting hypothesis testing, target de-risking, and quantitative outcome measurement.
- Discovery Biology: Enables hypothesis-driven studies of cortical injury and repair mechanisms.
- Screening: Provides reproducible, quantitative readouts for compound evaluation.
- Analytics: Supports statistical comparison of lesion size, behavioral outcomes, and recovery trajectories.
- Translational Research: Bridges discovery and preclinical phases with disease-relevant, standardized endpoints.
- Enterprise Reuse: Offers a platform adaptable to various cortical regions and compatible with in vivo imaging modalities.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in stroke research.
- Operational Value: Delivers high reproducibility, standardization, and scalability for cross-functional teams.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neurovascular therapeutic programs.
Implementation Considerations
- Requires expertise in stereotactic procedures and small animal surgery.
- Needs access to 561 nm laser systems and histological analysis infrastructure.
- Demands rigorous cross-team standardization of dosing, timing, and lesion targeting.
- Adaptable to different cortical regions and compatible with cranial window imaging setups.
- Dependent on precise technical execution to minimize variability and ensure reproducibility.
Biopharma FAQs
Why does null hypothesis testing matter for photothrombotic lesion validation?
Null hypothesis testing ensures that observed effects, such as infarct volume or behavioral changes, are attributable to the combined Rose Bengal and laser intervention rather than procedural artifacts, supporting robust target validation and mechanistic clarity.
How does independent variable isolation fit the photothrombosis discovery pipeline?
By controlling variables such as Rose Bengal dosing and laser application, the model isolates the effects of focal ischemia, enabling clear attribution of downstream biological responses and facilitating reliable screening of candidate interventions.
What do quantitative infarct volume measurements enable in preclinical stroke studies?
Quantitative infarct volume provides objective, reproducible endpoints for comparing experimental groups, supporting statistical rigor and enabling cross-study and cross-team data integration in therapeutic evaluation.
Why are replication requirements critical for cross-functional stroke research?
Replication ensures that findings are consistent across operators and sites, addressing the replication crisis and enabling reliable data sharing and decision-making across discovery, screening, and translational teams.
What statistical analysis capabilities are required before implementing photothrombotic stroke models?
Teams must be equipped to perform group comparisons, variance analysis, and outcome thresholding on endpoints such as infarct size and neurobehavioral scores to ensure data validity and actionable insights for portfolio advancement.
